Trademark: 87650626
Word
NUOPTII
Status
Dead
Status Code
605
Status Date
Tuesday, June 8, 2021
Serial Number
87650626
Mark Type
4000
Filing Date
Wednesday, October 18, 2017
Published for Opposition
Tuesday, May 1, 2018
Abandoned Date
Monday, June 7, 2021

Trademark Owner History
H. Lundbeck A-S - Owner At Publication

Classifications
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes
10 Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Trademark Events
Jun 8, 2021
Abandonment Notice E-Mailed - After Publication
Jun 8, 2021
Abandonment - After Publication
Jun 7, 2021
Teas Express Abandonment Received
Jan 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2021
Extension 5 Granted
Dec 4, 2020
Extension 5 Filed
Dec 21, 2020
Case Assigned To Intent To Use Paralegal
Dec 4, 2020
Teas Extension Received
Jun 5, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 3, 2020
Extension 4 Granted
Jun 3, 2020
Extension 4 Filed
Jun 3, 2020
Teas Extension Received
Dec 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 3, 2019
Extension 3 Granted
Dec 3, 2019
Extension 3 Filed
Dec 3, 2019
Teas Extension Received
Jun 4, 2019
Notice Of Approval Of Extension Request E-Mailed
May 31, 2019
Extension 2 Granted
May 31, 2019
Extension 2 Filed
May 31, 2019
Teas Extension Received
Dec 8, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 6, 2018
Extension 1 Granted
Dec 6, 2018
Extension 1 Filed
Dec 6, 2018
Teas Extension Received
Jun 26, 2018
Noa E-Mailed - Sou Required From Applicant
May 1, 2018
Official Gazette Publication Confirmation E-Mailed
May 1, 2018
Published For Opposition
Apr 11, 2018
Notification Of Notice Of Publication E-Mailed
Mar 23, 2018
Approved For Pub - Principal Register
Mar 23, 2018
Examiner's Amendment Entered
Mar 23, 2018
Notification Of Examiners Amendment E-Mailed
Mar 23, 2018
Examiners Amendment E-Mailed
Mar 23, 2018
Examiners Amendment -Written
Feb 1, 2018
Notification Of Priority Action E-Mailed
Feb 1, 2018
Priority Action E-Mailed
Feb 1, 2018
Priority Action Written
Jan 31, 2018
Teas Voluntary Amendment Received
Jan 26, 2018
Assigned To Examiner
Oct 27, 2017
New Application Office Supplied Data Entered In Tram
Oct 21, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24